Šalis: Jungtinės Valstijos
kalba: anglų
Šaltinis: NLM (National Library of Medicine)
CALCIPOTRIENE (UNII: 143NQ3779B) (CALCIPOTRIENE - UNII:143NQ3779B), CLOBETASOL PROPIONATE (UNII: 779619577M) (CLOBETASOL - UNII:ADN79D536H)
Sincerus Florida, LLC
TOPICAL
PRESCRIPTION DRUG
unapproved drug other
CALCIPOTRIENE 0.005% / CLOBETASOL PROPIONATE 0.05%- CALCIPOTRIENE 0.005% / CLOBETASOL PROPIONATE 0.05% SOLUTION SINCERUS FLORIDA, LLC _Disclaimer: This drug has not been found by FDA to be safe and effective, and this labeling has not been_ _approved by FDA. For further information about unapproved drugs, click here._ ---------- CALCIPOTRIENE 0.005% / CLOBETASOL PROPIONATE 0.05% DIRECTIONS FOR USE. SINCERUS FLORIDA, LLC. ADVERSE REACTIONS ACTIVE, INACTIVE NDC 72934- 4029-3 CALCIPOTRIENE USP 0.005% / CLOBETASOL PROPIONATE USP 0.05%. SOLUTION 60 GM CALCIPOTRIENE 0.005% / CLOBETASOL PROPIONATE 0.05% calcipotriene 0.005% / clobetasol propionate 0.05% solution Sincerus Florida, LLC PRODUCT INFORMATION PRODUCT T YPE HUMAN PRESCRIPTION DRUG ITE M CODE (SOURCE ) NDC:729 34-40 29 ROUTE OF ADMINISTRATION TOPICAL ACTIVE INGREDIENT/ACTIVE MOIETY INGREDIENT NAME BASIS OF STRENGTH STRE NG TH CALCIPO TRIENE (UNII: 143NQ3779 B) (CALCIPOTRIENE - UNII:143NQ3779 B) CALCIPOTRIENE 0 .0 0 5 g in 10 0 g CLO BETASO L PRO PIO NATE (UNII: 779 6 19 577M) (CLOBETASOL - UNII:ADN79 D536 H) CLOBETASOL PROPIONATE 0 .0 5 g in 10 0 g PACKAG ING # ITEM CODE PACKAGE DESCRIPTION MARKETING START DATE MARKETING END DATE 1 NDC:729 34-40 29 - 3 6 0 g in 1 BOTTLE, PUMP; Type 0 : No t a Co mbinatio n Pro duc t 0 5/20 /20 19 MARKETING INFORMATION MARKE TING CATE GORY APPLICATION NUMBE R OR MONOGRAPH CITATION MARKE TING START DATE MARKE TING END DATE unappro ved drug o ther 0 5/20 /20 19 LABELER - Sincerus Florida, LLC (080105003) ESTABLISHMENT NAME AD D RE S S ID/FEI BUSINE SS OPE RATIONS Sincerus Flo rida, LLC 0 8 0 10 50 0 3 ma nufa c ture (729 34-40 29 ) Revised: 5/2019 Perskaitykite visą dokumentą